2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Mitochondrial dysfunction in diabetic kidney disease

JM Forbes, DR Thorburn - Nature Reviews Nephrology, 2018 - nature.com
Globally, diabetes is the leading cause of chronic kidney disease and end-stage renal
disease, which are major risk factors for cardiovascular disease and death. Despite this …

[PDF][PDF] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

PM Elliott, A Anastasakis, MA Borger… - Polish Heart …, 2014 - journals.viamedica.pl
Kardiomiopatie definiuje się jako strukturalne oraz funkcjonalne nieprawidłowości mięśnia
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …

Friedreich's ataxia: clinical features, pathogenesis and management

A Cook, P Giunti - British medical bulletin, 2017 - academic.oup.com
Introduction Friedreich's ataxia is the most common inherited ataxia. Sources of data
Literature search using PubMed with keywords Friedreich's ataxia together with published …

Targeted therapies in pediatric and adult patients with hypertrophic heart disease: from molecular pathophysiology to personalized medicine

E Monda, A Bakalakos, M Rubino, F Verrillo… - Circulation: Heart …, 2023 - Am Heart Assoc
Hypertrophic cardiomyopathy is a myocardial disease defined by an increased left
ventricular wall thickness not solely explained by abnormal loading conditions. It is often …

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial

S Romano, G Coarelli, C Marcotulli, L Leonardi… - The Lancet …, 2015 - thelancet.com
Background Our previous study in patients with cerebellar ataxias of different causes
showed significant benefit of riluzole after 8 weeks. We aimed to confirm these results in …

The autosomal recessive cerebellar ataxias

M Anheim, C Tranchant, M Koenig - New England Journal of …, 2012 - Mass Medical Soc
The Autosomal Recessive Cerebellar Ataxias | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Mitochondria as a drug target in ischemic heart disease and cardiomyopathy

AM Walters, GA Porter Jr, PS Brookes - Circulation research, 2012 - Am Heart Assoc
Ischemic heart disease is a significant cause of morbidity and mortality in Western society.
Although interventions, such as thrombolysis and percutaneous coronary intervention, have …

Consensus paper: management of degenerative cerebellar disorders

W Ilg, AJ Bastian, S Boesch, RG Burciu, P Celnik… - The Cerebellum, 2014 - Springer
Abstract Treatment of motor symptoms of degenerative cerebellar ataxia remains difficult.
Yet there are recent developments that are likely to lead to significant improvements in the …

Autosomal recessive cerebellar ataxias: paving the way toward targeted molecular therapies

M Synofzik, H Puccio, F Mochel, L Schöls - Neuron, 2019 - cell.com
Autosomal-recessive cerebellar ataxias (ARCAs) comprise a heterogeneous group of rare
degenerative and metabolic genetic diseases that share the hallmark of progressive …